Literature DB >> 6786433

Routine neonatal screening for phenylketonuria in the United Kingdom 1964-78. Medical Research Council Steering Committee for the MRC/DHSS Phenylketonuria Register.

.   

Abstract

From 1964 to 1968, despite a general policy of routine neonatal screening for phenylketonuria that was usually carried out using the Phenistix nappy test, half to one-quarter of all cases reported to the register had been missed in the screening programme and had not been detected before the age of 4 months. In about two-thirds of the "missed" cases no screening test had been carried out, and in one-third a urine test had been performed but had given a false-negative result. In 1968-9 the screening programme was reorganised according to recommendations made in a Government circular (HM (69) 72), which proposed that a specimen of blood should be obtained by heel prick from all newborn infants between the 6th and 14th day of life and be tested in a central laboratory for the presence of raised blood phenylalanine concentrations. The senior medical officers of the various regions were made responsible for ensuring that all infants were tested. By 1974 only 1 to 2% of surviving infants were not being tested for phenylketonuria in the neonatal period, and only five of the 357 cases born between 1974 and 1978 and notified to the register had been diagnosed after the age of 3 months.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786433      PMCID: PMC1505602          DOI: 10.1136/bmj.282.6277.1680

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  APPLICATION OF A SIMPLE MICROMETHOD TO THE SCREENING OF PLASMA FOR A VARIETY OF AMINOACIDOPATHIES.

Authors:  C R SCRIVER; E DAVIES; A M CULLEN
Journal:  Lancet       Date:  1964-08-01       Impact factor: 79.321

2.  Screening for inherited metabolic disease in Wales using urine-impregnated filter paper.

Authors:  D M Bradley
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

3.  Phenylalaninaemia. Differential diagnosis.

Authors:  M E Blaskovics; G E Schaeffler; S Hack
Journal:  Arch Dis Child       Date:  1974-11       Impact factor: 3.791

4.  Maternal phenylketonuria. Detrimental effects on embryogenesis and fetal development.

Authors:  R O Fisch; D Doeden; L L Lansky; J A Anderson
Journal:  Am J Dis Child       Date:  1969-12

5.  Phenylketonuria. Mass screening of newborns in Ireland.

Authors:  S F Cahalane
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

6.  Mass screening of the newborn for metabolic disease.

Authors:  L I Woolf
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

7.  Evaluation of treatment begun in first three mohs oflife in 184 cases of phenylketonuria.

Authors:  F P Hudson; V L Mordaunt; I Leahy
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

8.  New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.

Authors:  I Smith; B E Clayton; O H Wolff
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

9.  Natural history of phenylketonuria and influence of early treatment.

Authors:  I Smith; O H Wolff
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

10.  Maternal hyperphenylalaninaemia in the normal and phenylketonuric mother and its influence on maternal plasma and fetal fluid amino acid concentrations.

Authors:  F Cockburn; J W Farquhar; J O Forfar; M Giles; S P Robins
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-08
View more
  5 in total

Review 1.  The Glasgow Register of Congenital Anomalies 1972-88: a critical review.

Authors:  D H Stone
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Dihydropteridine reductase activity in eluates from dried blood spots: automation of an assay for a national screening service.

Authors:  I M Surplice; P D Griffiths; A Green; R J Leeming
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Neuropsychological outcome of experimental manipulation of phenylalanine intake in treated phenylketonuria.

Authors:  P Griffiths; N Ward; A Harvie; F Cockburn
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

4.  Intelligence in mild atypical phenylketonuria.

Authors:  P M Costello; M G Beasley; S L Tillotson; I Smith
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

5.  Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre.

Authors:  George Altman; Kamran Hussain; Diane Green; Boyd J G Strauss; Gisela Wilcox
Journal:  Orphanet J Rare Dis       Date:  2021-12-20       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.